Banco Bilbao Vizcaya Argentaria, S.A. Unity Biotechnology, Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$2.94 - $12.43 $126,925 - $536,627	-43,172 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$5.28 - $9.67 $227,948 - $417,473	43,172 New	43,172 $374,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.